Could fewer islet cells be transplanted in type 1 diabetes?

BMJ

Volumn 322, Issue 7290, 2001, Pages 861-

  Ryan, Edmond ^a   Warnock, Garth L ^a   Kneteman, Norman M ^a   Lakey, Jonathan ^a   Korbutt, Gregory S ^a   Rajotte, Ray V ^a   Shapiro, James ^b   Waugh, Norman ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University of Alberta ^*

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PANCREAS ISLET CELL; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SURVIVAL;

DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; RISK FACTORS;

EID: 0035820359     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.322.7290.861     Document Type: Letter

References (2)

1. Waugh N. BMJ 2000; 321: 1534. (16 December.)
2. Serup P, Madsen OD, Mandrup-Poulsen T. Islet and stem cell transplantation for treating diabetes. BMJ 2001; 322: 29–32. (6 January.)